Published in Transfus Med Rev on July 01, 1998
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2011) 1.74
Postoperative intracranial haemorrhage: a review. Neurosurg Rev (2011) 1.69
Autologous transfusion. BMJ (2002) 1.52
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus (2011) 1.45
Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2010) 1.26
Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2002) 1.16
Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg (2002) 0.95
Autologous blood in obstetrics: where are we going now? Blood Transfus (2011) 0.87
Blood Management Strategies in Total Knee Arthroplasty. Knee Surg Relat Res (2016) 0.77
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database Syst Rev (2016) 0.76
Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach. Obstet Gynecol Surv (2016) 0.75
Determinants of allogeneic transfusion among patients who had an autologous blood procedure, France. Eur J Epidemiol (2004) 0.75
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
The Canadian CT Head Rule for patients with minor head injury. Lancet (2001) 7.91
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA (1999) 4.31
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2007) 3.28
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Evidence-based medicine and the practicing clinician. J Gen Intern Med (1999) 2.99
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Variation in emergency department use of cervical spine radiography for alert, stable trauma patients. CMAJ (1997) 2.79
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg (1998) 2.44
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med (1999) 2.27
Initiating, conducting and maintaining guidelines development programs. CMAJ (1993) 2.24
Antithrombotic therapy in atrial fibrillation. Chest (1992) 2.21
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1999) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Antithrombotic therapy in atrial fibrillation. Chest (1995) 2.08
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax (2007) 1.81
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol (2000) 1.75
Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost (2010) 1.69
Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med (1998) 1.68
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66
The Canadian CT Head Rule Study for patients with minor head injury: rationale, objectives, and methodology for phase I (derivation). Ann Emerg Med (2001) 1.65
Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. CMAJ (2001) 1.54
When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ (2000) 1.51
Cyclosporin prevents diabetes in BB Wistar rats. Lancet (1983) 1.50
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Autologous versus allogeneic transfusion: patients' perceptions and experiences. CMAJ (1999) 1.45
An economic analysis of the Ottawa knee rule. Ann Emerg Med (1999) 1.43
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. N Engl J Med (1994) 1.43
Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41
Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. Bipolar Disord (2005) 1.41
A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg (1999) 1.40
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) 1.37
Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg (1997) 1.32
How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ (2001) 1.31
Variation in ED use of computed tomography for patients with minor head injury. Ann Emerg Med (1997) 1.29
Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med (1992) 1.28
Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med (2000) 1.23
Physician communication with children and parents. Pediatrics (1982) 1.23
Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1996) 1.21
Awareness and use of the Ottawa ankle and knee rules in 5 countries: can publication alone be enough to change practice? Ann Emerg Med (2001) 1.19
Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg (1998) 1.17
Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2002) 1.16
Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: a metaanalysis. Ann Emerg Med (1996) 1.15
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Cost-effectiveness analysis of the Ottawa Ankle Rules. Ann Emerg Med (1995) 1.13
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax (2006) 1.11
Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med (1983) 1.10
A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res (1994) 1.10
Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique. Med Decis Making (2001) 1.10
A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply. CMAJ (2001) 1.10
Penetration of the unwounded immature mouse cornea and conjunctiva by Pseudomonas: SEM-TEM analysis. Invest Ophthalmol Vis Sci (1980) 1.10
Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09
Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG (2006) 1.08
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06
Surveying physicians to determine the minimal important difference: implications for sample-size calculation. J Clin Epidemiol (1999) 1.06
Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant (2004) 1.05
The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana. Mol Biochem Parasitol (2001) 1.05
Emergency physicians' attitudes toward and use of clinical decision rules for radiography. Acad Emerg Med (1998) 1.05
A survey of clinician attitudes and management practices in hypertension. J Hum Hypertens (1997) 1.04
Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest (1999) 1.04
Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med (1998) 1.02
Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant (2007) 1.02
Volume definition in radiotherapy planning for lung cancer: how the radiologist can help. Cancer Imaging (2006) 1.01
Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med (2001) 1.01
Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. Int J Technol Assess Health Care (1999) 1.00
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood (1999) 1.00
Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med (1995) 0.98
Feasibility, limits and problems of clinical studies in Intensive Care Unit. Minerva Anestesiol (2007) 0.96
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart (2002) 0.95
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2000) 0.95
Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2004) 0.95
Direct and indirect costs of management of long-term warfarin therapy in Canada. J Thromb Haemost (2010) 0.95
Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group. CMAJ (1996) 0.94